Serum RNASE1 levels were significantly higher in patients with severe disease activity compared with those with inactive disease, whereas patients with mild or moderate activity showed a trend toward increased RNASE1 levels that did not reach statistical significance ( Figure 2C ).
← all excerpts
Serum RNASE1 as a biomarker for disease activity and lupus nephritis in systemic lupus erythematosus.
1
—
—